An in-depth understanding of the role and regulation of TAGLN2 in gliomas may be useful in identifying novel therapeutic vulnerabilities in TAGLN2-associated signaling pathways driving proliferation, invasion and therapeutic resistance mechanisms in gliomas. The gene discussed is TAGLN2; the disease is glioma.